 Juan Idrovo
Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burns | 12 | 2025 | 374 | 4.330 |
Why?
| | Liver | 6 | 2025 | 1899 | 1.980 |
Why?
| | Liver Diseases | 3 | 2025 | 305 | 1.770 |
Why?
| | Aging | 5 | 2025 | 1973 | 1.070 |
Why?
| | Reperfusion Injury | 3 | 2015 | 292 | 0.930 |
Why?
| | Laparotomy | 1 | 2025 | 113 | 0.890 |
Why?
| | Blood Component Transfusion | 1 | 2026 | 102 | 0.890 |
Why?
| | Postoperative Complications | 4 | 2026 | 2977 | 0.870 |
Why?
| | Mitochondria, Liver | 1 | 2025 | 70 | 0.850 |
Why?
| | 4-Butyrolactone | 2 | 2015 | 23 | 0.810 |
Why?
| | Aminoimidazole Carboxamide | 2 | 2015 | 12 | 0.800 |
Why?
| | Hepatocytes | 1 | 2025 | 224 | 0.790 |
Why?
| | Blood Transfusion | 1 | 2026 | 409 | 0.740 |
Why?
| | Wound Healing | 2 | 2016 | 355 | 0.740 |
Why?
| | Mitochondrial Proteins | 1 | 2025 | 263 | 0.730 |
Why?
| | Caspases | 1 | 2023 | 233 | 0.720 |
Why?
| | Inflammation | 3 | 2020 | 2884 | 0.690 |
Why?
| | Hemorrhage | 1 | 2026 | 822 | 0.640 |
Why?
| | Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 11 | 0.630 |
Why?
| | Severe Acute Respiratory Syndrome | 1 | 2020 | 19 | 0.630 |
Why?
| | Mice | 14 | 2025 | 18356 | 0.610 |
Why?
| | Alcoholic Intoxication | 1 | 2019 | 76 | 0.560 |
Why?
| | Mice, Inbred C57BL | 7 | 2025 | 5993 | 0.560 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 391 | 0.540 |
Why?
| | Coronavirus Infections | 2 | 2020 | 384 | 0.540 |
Why?
| | Betacoronavirus | 2 | 2020 | 289 | 0.540 |
Why?
| | Animals | 19 | 2025 | 38102 | 0.530 |
Why?
| | Cytokines | 2 | 2025 | 2069 | 0.530 |
Why?
| | Wounds and Injuries | 1 | 2026 | 962 | 0.520 |
Why?
| | Aspartate Aminotransferases | 3 | 2025 | 85 | 0.500 |
Why?
| | Intestines | 2 | 2021 | 354 | 0.490 |
Why?
| | Transcriptome | 1 | 2023 | 1042 | 0.490 |
Why?
| | Alanine Transaminase | 3 | 2025 | 151 | 0.490 |
Why?
| | Hepatic Insufficiency | 1 | 2015 | 3 | 0.450 |
Why?
| | Adrenomedullin | 1 | 2015 | 5 | 0.440 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2012 | 49 | 0.440 |
Why?
| | Ribonucleotides | 1 | 2015 | 26 | 0.440 |
Why?
| | Lipogenesis | 1 | 2015 | 62 | 0.430 |
Why?
| | Complement Factor H | 1 | 2015 | 79 | 0.410 |
Why?
| | Skin | 2 | 2016 | 754 | 0.390 |
Why?
| | Shock, Hemorrhagic | 1 | 2016 | 199 | 0.390 |
Why?
| | Disease Models, Animal | 5 | 2025 | 4568 | 0.370 |
Why?
| | Pandemics | 2 | 2020 | 1711 | 0.360 |
Why?
| | Intestinal Mucosa | 4 | 2025 | 675 | 0.360 |
Why?
| | Age Factors | 4 | 2025 | 3346 | 0.360 |
Why?
| | Ribonucleosides | 1 | 2012 | 7 | 0.360 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2011 | 37 | 0.350 |
Why?
| | RNA-Binding Proteins | 1 | 2016 | 447 | 0.350 |
Why?
| | Enzyme Inhibitors | 1 | 2015 | 821 | 0.350 |
Why?
| | Renal Artery | 1 | 2011 | 43 | 0.340 |
Why?
| | Acute Lung Injury | 1 | 2015 | 307 | 0.340 |
Why?
| | Renal Circulation | 1 | 2011 | 75 | 0.340 |
Why?
| | Carnitine | 1 | 2012 | 91 | 0.340 |
Why?
| | Anti-Inflammatory Agents | 1 | 2015 | 478 | 0.340 |
Why?
| | Arterial Occlusive Diseases | 1 | 2011 | 90 | 0.330 |
Why?
| | Energy Metabolism | 2 | 2012 | 935 | 0.280 |
Why?
| | Apoptosis | 4 | 2025 | 2444 | 0.280 |
Why?
| | Sepsis | 1 | 2015 | 664 | 0.280 |
Why?
| | Rats, Sprague-Dawley | 4 | 2015 | 2525 | 0.270 |
Why?
| | Recovery of Function | 1 | 2012 | 716 | 0.260 |
Why?
| | Biomarkers | 3 | 2025 | 4302 | 0.260 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2020 | 1217 | 0.250 |
Why?
| | Kidney | 2 | 2012 | 1497 | 0.250 |
Why?
| | Hemothorax | 1 | 2026 | 19 | 0.240 |
Why?
| | Keratin-18 | 1 | 2025 | 12 | 0.230 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2026 | 56 | 0.230 |
Why?
| | Male | 14 | 2026 | 73011 | 0.230 |
Why?
| | Colon | 2 | 2025 | 309 | 0.230 |
Why?
| | Median Arcuate Ligament Syndrome | 1 | 2025 | 8 | 0.230 |
Why?
| | Celiac Artery | 1 | 2025 | 20 | 0.230 |
Why?
| | Cough | 3 | 2020 | 124 | 0.220 |
Why?
| | Serum Amyloid A Protein | 1 | 2025 | 32 | 0.220 |
Why?
| | Kidney Transplantation | 1 | 2011 | 712 | 0.220 |
Why?
| | Kynurenine | 1 | 2025 | 114 | 0.220 |
Why?
| | Rats | 4 | 2015 | 5585 | 0.220 |
Why?
| | tau Proteins | 1 | 2025 | 105 | 0.210 |
Why?
| | Fever | 3 | 2020 | 320 | 0.210 |
Why?
| | Tryptophan | 1 | 2025 | 182 | 0.210 |
Why?
| | Dysbiosis | 2 | 2023 | 188 | 0.210 |
Why?
| | Acute Kidney Injury | 1 | 2012 | 874 | 0.200 |
Why?
| | Neovascularization, Physiologic | 2 | 2016 | 193 | 0.200 |
Why?
| | Gene Silencing | 1 | 2025 | 202 | 0.200 |
Why?
| | Interleukin-6 | 2 | 2020 | 780 | 0.200 |
Why?
| | Caspase 9 | 1 | 2023 | 55 | 0.190 |
Why?
| | bcl-X Protein | 1 | 2023 | 45 | 0.190 |
Why?
| | Peroxidase | 2 | 2015 | 168 | 0.190 |
Why?
| | Central Nervous System | 1 | 2025 | 282 | 0.190 |
Why?
| | STAT3 Transcription Factor | 1 | 2025 | 206 | 0.190 |
Why?
| | Cellular Senescence | 1 | 2025 | 226 | 0.190 |
Why?
| | Robotic Surgical Procedures | 1 | 2025 | 185 | 0.180 |
Why?
| | Travel | 2 | 2020 | 136 | 0.180 |
Why?
| | Fluorouracil | 1 | 2023 | 231 | 0.180 |
Why?
| | Caspase 3 | 1 | 2023 | 242 | 0.180 |
Why?
| | Female | 11 | 2026 | 79045 | 0.180 |
Why?
| | Reactive Oxygen Species | 1 | 2025 | 611 | 0.170 |
Why?
| | Dyspnea | 2 | 2020 | 250 | 0.170 |
Why?
| | Cell Survival | 1 | 2025 | 1104 | 0.170 |
Why?
| | Delirium | 1 | 2023 | 105 | 0.170 |
Why?
| | Tight Junctions | 1 | 2021 | 82 | 0.170 |
Why?
| | Malondialdehyde | 1 | 2021 | 31 | 0.170 |
Why?
| | Human papillomavirus 16 | 1 | 2021 | 27 | 0.170 |
Why?
| | Cell Proliferation | 2 | 2025 | 2514 | 0.160 |
Why?
| | Lipid Peroxidation | 1 | 2021 | 168 | 0.160 |
Why?
| | Chemokine CXCL1 | 1 | 2020 | 76 | 0.160 |
Why?
| | Papillomaviridae | 1 | 2021 | 116 | 0.160 |
Why?
| | Astrocytes | 1 | 2022 | 228 | 0.160 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 2021 | 90 | 0.160 |
Why?
| | Blood Cell Count | 1 | 2020 | 55 | 0.160 |
Why?
| | Humans | 18 | 2026 | 145783 | 0.150 |
Why?
| | Resistin | 1 | 2019 | 12 | 0.150 |
Why?
| | Gastric Inhibitory Polypeptide | 1 | 2019 | 13 | 0.150 |
Why?
| | Ghrelin | 1 | 2019 | 42 | 0.150 |
Why?
| | China | 1 | 2020 | 274 | 0.150 |
Why?
| | MicroRNAs | 1 | 2025 | 686 | 0.150 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2019 | 85 | 0.150 |
Why?
| | Adenosine Triphosphate | 2 | 2012 | 500 | 0.150 |
Why?
| | Glutathione | 1 | 2021 | 370 | 0.150 |
Why?
| | Interleukin-1beta | 1 | 2020 | 390 | 0.140 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2019 | 149 | 0.140 |
Why?
| | Leptin | 1 | 2019 | 248 | 0.130 |
Why?
| | Gastrointestinal Tract | 1 | 2020 | 204 | 0.130 |
Why?
| | Oxidative Stress | 1 | 2025 | 1360 | 0.130 |
Why?
| | Models, Animal | 1 | 2019 | 392 | 0.130 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1261 | 0.130 |
Why?
| | Gene Expression Profiling | 1 | 2023 | 1777 | 0.120 |
Why?
| | Adenocarcinoma | 1 | 2023 | 926 | 0.120 |
Why?
| | Respiratory Tract Infections | 1 | 2020 | 396 | 0.120 |
Why?
| | Microbiota | 1 | 2023 | 730 | 0.120 |
Why?
| | Alcoholism | 1 | 2023 | 826 | 0.110 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2015 | 112 | 0.110 |
Why?
| | Bacterial Load | 1 | 2015 | 67 | 0.110 |
Why?
| | Ethanol | 1 | 2019 | 631 | 0.110 |
Why?
| | Neutrophil Infiltration | 1 | 2015 | 107 | 0.110 |
Why?
| | Lung | 2 | 2020 | 4116 | 0.100 |
Why?
| | Adult | 6 | 2026 | 40881 | 0.100 |
Why?
| | Influenza, Human | 1 | 2020 | 624 | 0.100 |
Why?
| | Aged | 6 | 2025 | 26217 | 0.100 |
Why?
| | Hospitalization | 2 | 2020 | 2461 | 0.090 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 768 | 0.090 |
Why?
| | Lymph Nodes | 1 | 2015 | 509 | 0.090 |
Why?
| | Treatment Outcome | 3 | 2025 | 11794 | 0.090 |
Why?
| | Spasm | 1 | 2011 | 21 | 0.090 |
Why?
| | Edema | 1 | 2012 | 125 | 0.090 |
Why?
| | Ligands | 2 | 2023 | 668 | 0.080 |
Why?
| | Gallbladder Neoplasms | 1 | 2011 | 20 | 0.080 |
Why?
| | Constriction, Pathologic | 1 | 2011 | 249 | 0.080 |
Why?
| | Leukocytes | 1 | 2012 | 296 | 0.080 |
Why?
| | Blood Flow Velocity | 1 | 2011 | 421 | 0.080 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 2011 | 124 | 0.080 |
Why?
| | Living Donors | 1 | 2011 | 282 | 0.070 |
Why?
| | Blood Glucose | 1 | 2019 | 2344 | 0.070 |
Why?
| | Neutrophils | 1 | 2015 | 1127 | 0.070 |
Why?
| | Drug Therapy, Combination | 1 | 2012 | 1043 | 0.070 |
Why?
| | Insulin | 1 | 2019 | 2516 | 0.070 |
Why?
| | Fatty Acids | 1 | 2012 | 457 | 0.070 |
Why?
| | Breast Neoplasms | 1 | 2021 | 2393 | 0.070 |
Why?
| | Time Factors | 2 | 2026 | 7134 | 0.070 |
Why?
| | Signal Transduction | 1 | 2020 | 5224 | 0.060 |
Why?
| | Thoracostomy | 1 | 2026 | 27 | 0.060 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 2123 | 0.060 |
Why?
| | Thoracotomy | 1 | 2026 | 88 | 0.060 |
Why?
| | Retrospective Studies | 4 | 2026 | 17330 | 0.060 |
Why?
| | Risk Factors | 1 | 2020 | 10919 | 0.060 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2025 | 72 | 0.060 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2025 | 68 | 0.060 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2025 | 122 | 0.050 |
Why?
| | Neurofilament Proteins | 1 | 2025 | 79 | 0.050 |
Why?
| | Middle Aged | 5 | 2026 | 36309 | 0.050 |
Why?
| | Operative Time | 1 | 2025 | 181 | 0.050 |
Why?
| | Glypicans | 1 | 2023 | 11 | 0.050 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2025 | 231 | 0.050 |
Why?
| | Reoperation | 1 | 2026 | 637 | 0.050 |
Why?
| | Body Surface Area | 1 | 2022 | 34 | 0.050 |
Why?
| | Chemokines | 1 | 2023 | 217 | 0.050 |
Why?
| | Burn Units | 1 | 2022 | 41 | 0.050 |
Why?
| | Occludin | 1 | 2021 | 12 | 0.040 |
Why?
| | Permeability | 1 | 2021 | 169 | 0.040 |
Why?
| | Human papillomavirus 18 | 1 | 2021 | 12 | 0.040 |
Why?
| | Infectious Disease Incubation Period | 1 | 2020 | 5 | 0.040 |
Why?
| | Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 61 | 0.040 |
Why?
| | Influenza B virus | 1 | 2020 | 47 | 0.040 |
Why?
| | Pharyngitis | 1 | 2020 | 25 | 0.040 |
Why?
| | Organ Specificity | 1 | 2020 | 309 | 0.040 |
Why?
| | Influenza A virus | 1 | 2020 | 119 | 0.040 |
Why?
| | Esophageal Neoplasms | 1 | 2023 | 348 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2023 | 1547 | 0.040 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2023 | 883 | 0.030 |
Why?
| | Bacteria | 1 | 2023 | 766 | 0.030 |
Why?
| | Survival Analysis | 1 | 2020 | 1378 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2021 | 1723 | 0.030 |
Why?
| | Papillomavirus Infections | 1 | 2021 | 344 | 0.030 |
Why?
| | Hippocampus | 1 | 2022 | 973 | 0.030 |
Why?
| | Homeostasis | 1 | 2020 | 644 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2023 | 3551 | 0.030 |
Why?
| | Cognition | 1 | 2023 | 1271 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2933 | 0.020 |
Why?
| | Prognosis | 1 | 2021 | 4330 | 0.020 |
Why?
| | Electronic Health Records | 1 | 2020 | 1202 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2770 | 0.020 |
Why?
| | Young Adult | 1 | 2025 | 14254 | 0.020 |
Why?
| | Adolescent | 1 | 2025 | 22577 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2011 | 8347 | 0.010 |
Why?
|
|
Idrovo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|